Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Recruiting
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2019-01-02
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 700
- Registration Number
- NCT03791034
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion
Completed
- Conditions
- RevascularizationPercutaneous Coronary InterventionErythrocyte Transfusion
- First Posted Date
- 2018-12-27
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 28322
- Registration Number
- NCT03788148
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of
The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients
Completed
- Conditions
- Platelet Aggregation InhibitorsPercutaneous Coronary InterventionHydroxymethylglutaryl-coa Reductase InhibitorsCompliance, MedicationAdherence, MedicationPersistence, Medication
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2018-12-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 47291
- Registration Number
- NCT03785509
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of
The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery
Completed
- Conditions
- Chronic Post-Procedural PainBreast Cancer
- Interventions
- Other: acute postoperative pain
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 89
- Registration Number
- NCT03782896
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT03780608
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study
Completed
- Conditions
- Erythrocyte TransfusionPercutaneous Coronary InterventionRevascularization
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 48786
- Registration Number
- NCT03776266
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of
The Effect of a Ankle Assist Robot on Gait Function and Cardiopulmonary Metabolic Efficiency in Stroke Patients
Not Applicable
Completed
- Conditions
- StrokeGait, Hemiplegic
- Interventions
- Device: Ankle Assist Robot
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT03767205
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL
Completed
- Conditions
- Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT03766516
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-Gu, Korea, Republic of
Intraoperative Nociception and Postoperative Pain
Completed
- Conditions
- Pain, PostoperativeNociceptive PainAnalgesics
- Interventions
- Device: SPI group
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2019-07-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03761433
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT03758729
© Copyright 2025. All Rights Reserved by MedPath